← Back to guidelines
Endocrinology9 papers

Osteoarthritis of joint of hand

Last edited: 4/15/2026

Overview

Osteoarthritis of the hand involves degeneration of articular cartilage, leading to pain, stiffness, and functional impairment primarily affecting the distal interphalangeal (DIP) and proximal interphalangeal (PIP) joints. 2

Diagnosis

  • Clinical history and physical examination focusing on joint pain, swelling, and limited range of motion.
  • Radiographic imaging (X-rays) to assess joint space narrowing, osteophyte formation, and subchondral bone changes.
  • No specific laboratory tests are typically required unless to rule out other inflammatory conditions.
  • Management

  • First-line treatments:
  • - Non-pharmacological: Hand therapy, splinting, and activity modification. - Pharmacological: Analgesics (e.g., acetaminophen) and NSAIDs for pain relief. 2
  • Adjunctive treatments:
  • - Intra-articular corticosteroid injections for localized pain relief. - Hyaluronic acid injections may be considered in some cases, though evidence varies. - Physical therapy focusing on strengthening and flexibility exercises.

    Special Populations

  • Elderly: Increased prevalence; management focuses on minimizing functional decline and pain management. 2
  • Access to Care: Medicare patients may face significant travel barriers to rheumatologist care, potentially impacting timely management. (Evidence: Moderate) 1
  • Key Recommendations

  • Utilize non-pharmacological interventions such as splinting and physical therapy to maintain function and reduce pain in patients with hand osteoarthritis. (Evidence: Moderate) 2
  • Consider intra-articular corticosteroid injections for patients with localized pain and functional impairment, especially in DIP and PIP joints. (Evidence: Moderate) 2
  • Address potential barriers to rheumatology care, particularly for elderly Medicare beneficiaries, to ensure timely and effective management. (Evidence: Moderate) 1
  • References

    1 Schmajuk G, Tonner C, Yazdany J. Factors associated with access to rheumatologists for Medicare patients. Seminars in arthritis and rheumatism 2016. link 2 Golding D, Wilson P. Rheumatism and the menopause. The Practitioner 1989. link

    Original source

    1. [1]
      Factors associated with access to rheumatologists for Medicare patients.Schmajuk G, Tonner C, Yazdany J Seminars in arthritis and rheumatism (2016)
    2. [2]
      Rheumatism and the menopause.Golding D, Wilson P The Practitioner (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG